UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1663-1669

2012

Volltextzugriff (PDF)

Remission is good - relapse is bad

Haematologica (Roma), 2018-01, Vol.103 (1), p.4-5

Gaynon, Paul S

2018

Volltextzugriff (PDF)

Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Journal of clinical oncology, 2014-05, Vol.32 (13), p.1331-1337

2014

Volltextzugriff (PDF)

Historical Controls?

Haematologica (Roma), 2017-03, Vol.102 (3), p.e117-e117

Gaynon, Paul S

2017

Volltextzugriff (PDF)

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5175-5181

2009

Volltextzugriff (PDF)

Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial

The lancet oncology, 2012-09, Vol.13 (9), p.906-915

2012

Volltextzugriff (PDF)

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

Journal of clinical oncology, 2010-02, Vol.28 (4), p.648-654

2010

Volltextzugriff (PDF)

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

Haematologica (Roma), 2022-10, Vol.107 (10), p.2295-2303

2022

Volltextzugriff (PDF)

Obesity and Outcome in Pediatric Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2063-2069

2007

Volltextzugriff (PDF)

Outcome After Relapse Among Children With Standard-Risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study CCG-1952

Journal of clinical oncology, 2007-12, Vol.25 (36), p.5800-5807

2007

Volltextzugriff (PDF)

Young Adults With Acute Lymphoblastic Leukemia Have an Excellent Outcome With Chemotherapy Alone and Benefit From Intensive Postinduction Treatment: A Report From the Children's Oncology Group

Journal of clinical oncology, 2009-11, Vol.27 (31), p.5189-5194

2009

Volltextzugriff (PDF)

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1917-1923

2006

Volltextzugriff (PDF)

Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group

Blood, 2011-03, Vol.117 (11), p.3010-3015

2011

Volltextzugriff (PDF)

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Pediatric blood & cancer, 2010-09, Vol.55 (3), p.421-429

2010

Volltextzugriff (PDF)

Preexisting or therapy-induced mutations in relapsed acute lymphoblastic leukemia?

Blood, 2020-11, Vol.136 (19), p.2233-2235

2020

Volltextzugriff (PDF)

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

The Lancet (British edition), 2002-06, Vol.359 (9321), p.1909-1915

2002

Volltextzugriff (PDF)

A new standard of care for childhood T‐cell acute lymphoblastic leukemia?

Pediatric blood & cancer, 2021-10, Vol.68 (10), p.e29238-n/a

2021

Volltextzugriff (PDF)

Methotrexate and asparaginase: not so simple

Leukemia & lymphoma, 2019-10, Vol.60 (12), p.2849-2850

Gaynon, Paul S.

2019

Volltextzugriff (PDF)

Bone Marrow Transplantation Versus Prolonged Intensive Chemotherapy for Children With Acute Lymphoblastic Leukemia and an Initial Bone Marrow Relapse Within 12 Months of the Completion of Primary Therapy: Children's Oncology Group Study CCG-1941

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3150-3156

2006

Volltextzugriff (PDF)

Mercaptopurine in childhood acute lymphoblastic leukaemia

The lancet oncology, 2017-04, Vol.18 (4), p.425-426

Gaynon, Paul S

2017

Volltextzugriff (PDF)

Childhood acute lymphoblastic leukaemia and relapse

British journal of haematology, 2005-12, Vol.131 (5), p.579-587

Gaynon, Paul S.

2005

Volltextzugriff (PDF)

Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients

PloS one, 2013-11, Vol.8 (11), p.e80732

2013

Volltextzugriff (PDF)

The Second Time is Sweeter After All

British journal of haematology, 2017-02, Vol.176 (4), p.511-512

Gaynon, Paul S.

2017

Volltextzugriff (PDF)

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization

Journal of clinical oncology, 2018-10, Vol.36 (29), p.2926-2934

2018

Volltextzugriff (PDF)

1 – 25 von 264

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(224)

Publikationsform

Artikel
(263)
Berichte
(1)

Sprache

Englisch
(264)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(165)
Life Sciences & Biomedicine
(164)
Humans
(163)
Child
(138)
Oncology
(112)
Male
(105)
Female
(103)
Child, Preschool
(101)
Hematology
(95)
Biological And Medical Sciences
(83)
Infant
(83)
Medical Sciences
(83)
Adolescent
(74)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(72)
Treatment Outcome
(63)
Hematologic And Hematopoietic Diseases
(61)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(60)
Pediatrics
(49)
Prognosis
(45)
Acute Lymphoblastic Leukemia
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

Remission is good - relapse is bad

Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Historical Controls?

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

Obesity and Outcome in Pediatric Acute Lymphoblastic Leukemia

Outcome After Relapse Among Children With Standard-Risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study CCG-1952

Young Adults With Acute Lymphoblastic Leukemia Have an Excellent Outcome With Chemotherapy Alone and Benefit From Intensive Postinduction Treatment: A Report From the Children's Oncology Group

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia

Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): A therapeutic advances in childhood leukemia (TACL) consortium study

Preexisting or therapy-induced mutations in relapsed acute lymphoblastic leukemia?

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

A new standard of care for childhood T‐cell acute lymphoblastic leukemia?

Methotrexate and asparaginase: not so simple

Bone Marrow Transplantation Versus Prolonged Intensive Chemotherapy for Children With Acute Lymphoblastic Leukemia and an Initial Bone Marrow Relapse Within 12 Months of the Completion of Primary Therapy: Children's Oncology Group Study CCG-1941

Mercaptopurine in childhood acute lymphoblastic leukaemia

Childhood acute lymphoblastic leukaemia and relapse

Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients

The Second Time is Sweeter After All

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization

Suchergebnisse filtern